Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
GLP-1 (glucagon-like peptide-1) analogues have emerged as game-changers in the management of type 2 diabetes and obesity, thanks to their dual role in glucose regulation and weight reduction
Without enough, your body begins breaking down its own muscle tissue for energy
We obtained the data for this review from PubMed, Scopus, Web of Science, and ClinicalTrials.gov, using the following keywords: obesity, type 2 diabetes, new drug treatment, recent developments, clinical studies, G-protein-coupled receptor, glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic polypeptide receptor agonist, glucagon receptor agonist, dual agonist, and triple agonist. 2
Research has explored potential benefits related to: Improved lipid markers Support for cardiovascular function Improved metabolic efficiency These benefits are generally supportive rather than therapeutic
The company states that it has served over 300,000 members and that clinicians have booked more than one million consultations
US$ 26.84
US$ 29.55
US$ 23.41
US$ 26.72
US$ 25.05
US$ 22.38
US$ 28.27
US$ 27.88
